User profiles for Binayak Sinha
 | Binayak SinhaConsultant Endocrinologist Verified email at fortishealthcare.com Cited by 1685 |
Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and …
B Sinha, S Ghosal - Diabetes research and clinical practice, 2019 - Elsevier
Aim To assess the effects DPP-4i; SGLT2-i & GLP1-RA on CV death, MI, stroke and hHF. This
is probably the first meta-analysis to assess the effects of these drugs on MI and stroke in …
is probably the first meta-analysis to assess the effects of these drugs on MI and stroke in …
Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related …
S Ghosal, B Sinha, M Majumder, A Misra - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Introduction and aims: To prevent the spread of coronavirus disease (COVID19) total lockdown
is in place in India from March 24, 2020 for 21 days. In this study, we aim to assess the …
is in place in India from March 24, 2020 for 21 days. In this study, we aim to assess the …
[HTML][HTML] Androgen generation in adipose tissue in women with simple obesity–a site-specific role for 17β-hydroxysteroid dehydrogenase type 5
M Quinkler, B Sinha, JW Tomlinson… - Journal of …, 2004 - joe.bioscientifica.com
Women with polycystic ovary syndrome (PCOS) have high circulating androgens, thought to
originate from ovaries and adrenals, and frequently suffer from the metabolic syndrome …
originate from ovaries and adrenals, and frequently suffer from the metabolic syndrome …
Expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity
JW Tomlinson, B Sinha, I Bujalska… - The Journal of …, 2002 - academic.oup.com
Central obesity is associated with increased morbidity and mortality. Preadipocyte proliferation
and differentiation contribute to increases in adipose tissue mass, yet the mechanisms …
and differentiation contribute to increases in adipose tissue mass, yet the mechanisms …
[HTML][HTML] Exploring the comparative cardiovascular death benefits of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network …
S Ghosal, B Sinha - Frontiers in Endocrinology, 2023 - frontiersin.org
Background and aims Cardiovascular death (CV death) is the most objective component of
the primary or secondary endpoint in cardiovascular outcome trials (CVOTs) conducted with …
the primary or secondary endpoint in cardiovascular outcome trials (CVOTs) conducted with …
[HTML][HTML] A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
S Ghosal, D Datta, B Sinha - Scientific Reports, 2021 - nature.com
Abstract Treatment options for nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D),
two conditions which coexist, are limited though weight loss is an important strategy to …
two conditions which coexist, are limited though weight loss is an important strategy to …
[HTML][HTML] A meta-analysis of the effect of sodium glucose cotransporter-2 inhibitors on metabolic parameters in patients with polycystic ovary syndrome
B Sinha, S Ghosal - Frontiers in endocrinology, 2022 - frontiersin.org
Objective Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among
women of childbearing age and is associated with multiple morbidities. However, treatment for …
women of childbearing age and is associated with multiple morbidities. However, treatment for …
Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases-March 14th 2020)
S Ghosal, S Sengupta, M Majumder, B Sinha - Diabetes & Metabolic …, 2020 - Elsevier
Introduction and Aims: No valid treatment or preventative strategy has evolved till date to
counter the SARS CoV 2 (Novel Coronavirus) epidemic that originated in China in late 2019 …
counter the SARS CoV 2 (Novel Coronavirus) epidemic that originated in China in late 2019 …
[HTML][HTML] Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials
B Sinha, S Ghosal - Scientific Reports, 2020 - nature.com
The safety and usefulness of pioglitazone (Pio) is repeatedly called into question due to the
contradictory information available about it. A meta-analysis and risk benefit assessment …
contradictory information available about it. A meta-analysis and risk benefit assessment …
Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: a cohort analysis
S Ghosal, B Arora, K Dutta, A Ghosh, B Sinha… - Diabetes & Metabolic …, 2020 - Elsevier
Lockdown due to the Coronavirus disease 2019 (COVID 19) pandemic may cause weight
gain and enhance the risk of type 2 diabetes mellitus (T2DM). We aimed to determine this risk …
gain and enhance the risk of type 2 diabetes mellitus (T2DM). We aimed to determine this risk …
